Wallace Lai, MD
Clinical Cardiac Electrophysiology · Salem, ORNPI 1578503249
Payments from drug & device makers
What this record shows
This record is dominated by other: $4,875 of the $7,720 with a category attached, or 63.1%. Angiodynamics, Inc. accounts for 63.1% of it on its own, with 29 other manufacturers making up the rest. Reporting peaked in 2022 at $5,177 and has fallen 92.7% since, to $375 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in OR, where the typical reported total is $7,720.
Across 135 payments — averaging $57.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Angiodynamics, Inc.$5K
- Novartis$618
- Johnson & Johnson$328
- Boston Scientific$226
- Medtronic$213
- Bard Peripheral Vascular, Inc.$184
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,84537%
- Other$4,87563%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Angiodynamics, Inc. | 1 | $4,875 |
| Novartis | 33 | $618 |
| Johnson & Johnson | 17 | $328 |
| Boston Scientific | 11 | $226 |
| Medtronic(2 entities) | 9 | $213 |
| Bard Peripheral Vascular, Inc. | 11 | $184 |
| E.r. Squibb & Sons, L.L.C. | 9 | $182 |
| Merck | 8 | $158 |
| Edwards Lifesciences | 1 | $127 |
| Amarin Pharma, Inc. | 2 | $126 |
| AstraZeneca | 7 | $109 |
| Impulse Dynamics (USA) Inc. | 1 | $58 |
| Lemaitre Vascular, Inc. | 2 | $54 |
| Amgen | 2 | $48 |
| KCI USA, Inc. | 2 | $46 |
| Cardiva Medical, Inc. | 2 | $44 |
| Tactile Systems Technology Inc | 2 | $41 |
| Inspire Medical Systems, Inc. | 2 | $33 |
| Cardinal Health 200 LLC | 2 | $30 |
| Terumo Medical Corporation | 1 | $30 |
| Cardiovascular Systems Inc. | 1 | $24 |
| CMP Pharma, Inc. | 1 | $23 |
| Teleflex LLC | 1 | $21 |
| Pfizer | 1 | $21 |
| Inari Medical, Inc. | 1 | $21 |
| Baxter Healthcare | 1 | $19 |
| Acera Surgical, Inc. | 1 | $17 |
| Covidien LP | 1 | $16 |
| Cordis US CORP. | 1 | $15 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Auryon Laser System 100-120 Vac$4,875
- Vascepa$122
How this compares
$7,720 in reported general payments places this provider in the 50th percentile of 37 clinical cardiac electrophysiology providers in Oregon.
See all clinical cardiac electrophysiology providers in Oregon →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 543 | $566,652 |
| XareltoRivaroxaban | 113 | $131,014 |
| EntrestoSacubitril/Valsartan | 41 | $44,873 |
| FarxigaDapagliflozin Propanediol | 30 | $19,047 |
| Flecainide Acetate | 234 | $10,025 |
| Metoprolol Succinate | 478 | $7,612 |
| Potassium Chloride | 113 | $3,280 |
| Torsemide | 92 | $2,524 |
| Amiodarone Hcl | 165 | $2,305 |
| Atorvastatin Calcium | 233 | $2,272 |
| SotalolSotalol Hcl | 84 | $1,718 |
| Losartan Potassium | 111 | $1,711 |
| Furosemide | 238 | $1,697 |
| Carvedilol | 112 | $1,542 |
| Amlodipine Besylate | 140 | $1,399 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $21 | $566,652543 claims |
| Johnson & JohnsonXarelto | $328 | $131,014113 claims |
| NovartisEntresto | $618 | $44,87341 claims |
| AstraZenecaFarxiga | $109 | $19,04730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 37 clinical cardiac electrophysiology providers in Oregon.
Other clinical cardiac electrophysiology in Salem
- Sandeep SahaSalem$52K
- Ashit PatelSalem$36K
- Matthew FedorSalem$5K
- Eric PutzSalem$91
- Robert FlorekHood River$376K
- Jeff HsingCorvallis$89K
- Nathaniel McConkeyPortland$56K
- Jonathan LowyBend$46K
- Edward ChengGresham$39K
- Michael Charles TanPortland$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.